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Abstract
Background: The trochanteric stabilizing plate (TSP) is used as an adjunct to the sliding hip screw (SHS) in unstable
trochanteric and subtrochanteric fractures. We wanted to describe the choice of implant for trochanteric fractures
with a focus on the TSP in Norway.
Methods: A total of 20,902 fractures from the Norwegian Hip Fracture Register treated surgically in 43 hospitals
from 2011 to 2017 were included. Logistic regression analyses were performed to detect factors potentially
influencing implant choice.
Results: The mean age was 83 years, and 15,137 (72%) were women. An SHS was used in 13,273 (63%) fractures, of
them 4407 (33%) with a TSP. Fracture classification was the most important determinant of TSP. In cases where an
SHS was used, the odds ratio (OR) for using a TSP was 14 for AO/OTA 31A2 fractures and 71 for AO/OTA 31A3 and
subtrochanteric fractures, compared to AO/OTA 31A1 fractures. The probability of receiving a TSP was higher in
urban, academic, and high-volume hospitals (OR 1.2 to 1.3) and lower in Central and Northern Norway (OR 0.3 to
0.7). The use of an intramedullary nail (IMN) (n = 7629 (36%)) was also to a degree decided by fracture classification
(OR 1.8 to 5.3). However, hospital factors, with OR 0.1 to 0.4 for IMN in academic, urban, and high-volume hospitals
and OR 1.5 to 2.6 outside South-Eastern Norway (all p < 0.001), were also important.
Conclusions: Fracture classification was the main determinant for TSP use. Any additional benefit from a TSP on
postoperative fracture stability or clinical outcome needs to be clarified.
Keywords: Hip fractures, Trochanteric fractures, Trochanteric stabilizing plate, Intramedullary nail, Sliding hip screw,
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Introduction
There is still an ongoing debate concerning the choice of
implant for trochanteric fractures [1–3]. The literature
on implant use is extensive, and studies comparing slid-
ing hip screws (SHS) and intramedullary nails (IMN) are
numerous [3–5]. The trochanteric stabilizing plate (TSP)
is an extension of the SHS, most often modular (Fig. 1).
It functions as a lateral buttress and is added to in-
crease stability and prevent medialization of the femoral
shaft. Due to its modularity, it offers the possibility to
enhance construct stability intraoperatively if required.
The use of the TSP as an adjunct to the SHS varies be-
tween regions and hospitals, and the literature on the
use and performance is scarce. Surgeon- and hospital-
related factors may influence implant use, both in the
absence of available evidence, and sometimes contrary
to the evidence. The purpose of this study was to de-
scribe the use of the TSP in trochanteric and subtro-
chanteric fractures in Norway from 2011 to 2017. The




We applied prospectively registered data from the
Norwegian Hip Fracture Register (NHFR) from 2011
to 2017. After the completion of the surgery, the sur-
geon reports information regarding the patient, the
fracture, and the operation to the NHFR on a 1-page
questionnaire. The completeness of reporting of pri-
mary procedures to the NHFR is 88% [6]. The dataset
used in the primary analysis consisted of all trochan-
teric and subtrochanteric fractures registered from
2011 to 2017. Pathological fractures, fractures in pa-
tients < 60 years old, and fractures operated with
other implants than SHS, SHS with TSP, or IMN
were excluded from the analyses. In addition, hospi-
tals were excluded if they either reported less than 50
cases to the NHFR in total during the study period
or had at least 1 year where no fractures were re-
ported (Fig. 2).
Classification of hospitals
Hospitals were characterized as (1) situated in one of
four national health regions; (2) low- or high-volume:
less than 100 reported cases per year was considered low
volume; (3) rural or urban: hospitals were classified as
urban if they were situated in an urban area with more
than 25,000 inhabitants; (4) academic or non-academic:
academic hospitals had university affiliation and aca-
demic staff in the orthopedic department; and (5) in
addition, hospitals were classified according to their sur-
gical practice, i.e., implant choice. Hospitals where tro-
chanteric fractures throughout the study period were
treated with > 90% IMN or > 90% SHS were classified as
“IMN hospitals” and “SHS hospitals,” respectively. Hos-
pitals with a development from > 90% SHS to less than
80% during the period were classified as “SHS to mixed
pattern hospitals.” Hospitals with a shift to > 90% IMN
during the period were labeled “change to IMN hospi-
tals.” Hospitals with none of these patterns were classi-
fied as “mixed pattern hospitals.”
Statistics
The analysis of change of implant use over time was per-
formed with chi-square comparing the different years.
To analyze implant use, we performed two multivariate
logistic regression analyses with either SHS with or with-
out TSP, or SHS or IMN as dependent variables. Only
fractures with complete datasets were included in the re-
gression analyses. The variables for the regression ana-
lyses were selected a priori based on a presumed effect
on implant choice, including patient, surgeon, and hos-
pital factors. Data from the regression analyses are pre-
sented with odds ratio (OR), 95% confidence interval
Fig. 1 Radiograph of sliding hip screw with a modular trochanteric
stabilizing plate in an AO/OTA 31A2 fracture (published with
patient consent)
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(CI) for OR, and p values. We used SPSS for Windows
version 24 (IBM Corp, Armonk, NY, USA).
Results
As of January 1, 2019, 20,902 fractures fulfilled the inclu-
sion criteria and were included in the analyses (Fig. 2).
The mean age of patients was 83.2 years, 72% were
women, and 26% had cognitive impairment (Table 1).
The number of trochanteric fractures and the distribu-
tion of subgroups remained relatively stable throughout
the period, ranging from 3090 fractures in 2017 to 3245
fractures in 2011 (Fig. 3).
The proportion of AO/OTA type A1 was 8454 frac-
tures (40%), and of A2, there were 8598 fractures (41%).
The number of A3 and subtrochanteric fractures as one
group was 3850 (18%). The range of variation in fracture
classification from 1 year to another was 37–43% A1,
39–42% A2, and 16–21% A3 and subtrochanteric frac-
tures. The use of TSP declined throughout the period
for all fracture types (p < 0.001) (Fig. 3). The use of IMN
increased, especially in the unstable fracture patterns (p
< 0.001). However, the SHS with or without the TSP
remained the most used implant for simple two-part
fractures (A1) (Fig. 3).
The classification of the 43 hospitals is shown in Table 2.
Fourteen hospitals, reporting 1/3 of the fractures, were
classified exclusively, or almost exclusively, as either
SHS (8 hospitals) or IMN (6 hospitals) throughout the
period. Twenty hospitals had a recognizable change in
treatment practice during the period with an increased
use of IMN. The largest group (13 hospitals, 42% of the
fractures) changed from an exclusive use of SHS to a
Fig. 2 Flow chart of fractures included in the study
Table 1 Baseline characteristics, AO/OTA fracture classification, and surgeon experience by choice of implant
Implant SHS SHS with TSP IMN All fractures
Number, n (% of total) 8866 (42) 4407 (21) 7629 (36) 20,902
Patient characteristics
Mean age (SD) 83.3 (8.6) 83.4 (8.8) 83.1 (8.7) 83.2 (8.7)
Women, n (%) 6241 (70) 3326 (75) 5570 (73) 15,137 (72)
ASA classes 1–2, n (%) 2972 (34) 1402 (32) 2543 (34) 6917 (34)
Cognitive impairment, n (%) 2395 (27) 1116 (25) 1879 (25) 5390 (26)
Fracture type and surgeon experience
AO/OTA 31A1, n (%) 5807 (69) 450 (5) 2197 (26) 8454 (100)
AO/OTA 31A2, n (%) 2706 (31) 2901 (34) 2991 (35) 8598 (100)
AO/OTA 31A3 and subtrochanteric fractures, n (%) 353 (9) 1056 (27) 2441 (63) 3850 (100)
Surgeon experience > 3 years, n (%) 5520 (68) 2853 (71) 5860 (81) 14,233 (73)
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mixed pattern between SHS and IMN during the period.
Seven hospitals (11% of the fractures), all “rural,” “low-
volume,” and “non-academic” hospitals, were classified
as “change to IMN hospitals,” i.e., an increase to > 90%
intramedullary nailing of all fracture types during the
study period. Three out of 6 “academic hospitals” (2702
fractures (13%)) were “SHS hospitals” throughout the
period. The other three were classified as “SHS to mixed
pattern hospitals.”
Use of trochanteric stabilizing plate
A total of 13,272 fractures were operated with an SHS in
the period, and an additional TSP was used in 4407
cases (33%). In stable type A1 fractures, the TSP was
used in 7% of the SHS surgeries (450 out of 6257). For
A2 fractures, the TSP was used in 52% of the SHS cases
(2901 out of 5607), and in unstable A3 and subtrochan-
teric fractures, 75% of the patients had an additional
TSP (1056 out of 1409). A total of 10,600 of these frac-
tures could be included in the multivariate logistic re-
gression analysis (Table 3).
Of these, 3292 fractures (31%) were operated with a
TSP. Fracture classification (stability) was the most
important determinant of whether a TSP was added or
not, with OR 14 for type A2 fractures and OR 71 for A3
and subtrochanteric fractures. We found a statistically
significant higher chance of getting a TSP in “academic,”
“urban,” and “high-volume” hospitals. The probability of
receiving a TSP was statistically significant less in Cen-
tral and Northern Norway. Women had a small but sta-
tistically significant higher chance of receiving a TSP
compared to men. Other patient factors and surgeon ex-
perience had limited impact. Overall, the 8 “SHS hospi-
tals” operated 1308 of 3808 fractures (34%) with an SHS
including a TSP, but the rate varied from 29 to 52% be-
tween hospitals (p < 0.001).
Use of intramedullary nail versus sliding hip screw
We performed a separate regression analysis to evaluate
determinants for the choice of SHS with or without a
TSP compared to an IMN (Table 4).
Fracture pattern was an important determinant for the
use of IMN (OR 2 to 5). All variables describing hospital
characteristics were statistically significant with low OR
(0.1 to 0.4) for “academic,” “urban,” and “high-volume”
hospitals. Analyses of the subgroups of hospitals
Fig. 3 Time trend for the choice of implant. Y-axis—number of fractures. X-axis—year of operation. a All trochanteric and subtrochanteric
fractures (n = 20,902). b Two-part trochanteric fractures (AO/OTA 31A1; n = 8454). c Multi-fragmentary trochanteric fractures (AO/OTA 31A2; n =
8598). d Inter- (AO/OTA 31A3) and subtrochanteric fractures (n = 3850)
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Table 2 Description of hospital-level implant choice and fracture proportion for trochanteric and subtrochanteric fractures
Hospital classification Hospitals (n) Fractures (n) % of the total number of fractures
All hospitals 43 20,902 100
Implant pattern
SHS hospitals 8 3808 18
IMN hospitals 6 3111 15
Change to IMN hospitals 7 2220 11
SHS to mixed pattern hospitals 13 8675 42
Mixed pattern hospitals 9 3088 15
Hospital volume
High-volume (≥ 100 cases/year) 7 8086 39
Low-volume (< 100 cases/year) 36 12,816 61
Location
Urban 18 13,750 66
Rural 25 7152 34
Administrative “health region”
Southern and Eastern Norway 19 12,197 58
Western Norway 7 4080 20
Central Norway 8 2870 14
Northern Norway 9 1755 8
Academic hospital
Academic 6 5218 25
Non-academic 37 15,684 75
Table 3 Logistic regression analysis of the use of trochanteric support plate (TSP) in adjunction to a sliding hip screw (SHS)
depending on patient characteristics, fracture classification, and hospital characteristics. The analysis was performed on 10,600 cases
operated with SHS (7308 (69%) without TSP and 3292 (31%) with TSP) with complete data
OR for TSP 95% CI for OR p
Patient characteristics
Higher age (years) 1.0 0.99–1.0 0.9
Female sex 1.2 1.1–1.3 0.004
ASA > 2 1.1 1.0–1.2 0.05
Cognitive impairment (yes) 1.1 0.97–1.2 0.2
Fracture type
AO/OTA 31A1 1
AO/OTA 31A2 14 12–16 < 0.001
AO/OTA 31A3 and subtrochanteric 71 54–93 < 0.001
Surgeon experience > 3 years 0.9 0.8–1.0 0.05
Hospital characteristics
Academic hospital 1.2 1.1–1.4 0.009
High-volume hospital (> 100 cases/year) 1.3 1.1–1.5 < 0.001
Urban hospital 1.2 1.0–1.4 0.01
Health region South-Eastern Norway 1
Health region Western Norway 0.9 0.82–1.1 0.4
Health region Central Norway 0.3 0.25–0.35 < 0.001
Health region Northern Norway 0.7 0.52–0.83 < 0.001
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according to hospital implant choice confirmed the pat-
tern on hospital-related factors and fracture classifica-
tion. For “mixed pattern” hospitals, the fracture
classification was the dominant factor, and for “SHS hos-
pitals” and “IMN hospitals,” the hospital-level factors
were the most important (data not shown). Experienced
surgeons, defined as surgeons having more than 3 years
of experience with surgical fracture treatment, used
IMN more frequently than less experienced surgeons
(OR 2). No patient characteristics influenced the choice
of implant significantly.
Discussion
The use of the trochanteric stabilizing plate was mainly
based on fracture classification and stability. Overall, a
TSP was used in one of five fractures and in one of three
cases where an SHS was used. The use of TSP declined
during the study period, mainly due to the increased use
of IMN. This change was most pronounced for unstable
fractures. The use of IMN also depended on fracture sta-
bility, but hospital factors seemed to play a larger role.
And overall, SHS was still the most frequently used im-
plant, but its use towards the end of the study period
was declining. An important reason for this change over
time was that 13 hospitals abandoned the exclusive use
of SHS in favor of IMN for unstable fracture patterns. In
addition, 7 hospitals started to use IMN, for all or almost
all fractures, regardless of fracture classification (Table
2). In addition to fracture stability, the south-east region
and an academic and urban setting were associated with
more frequent use of a TSP. Other than fracture classifi-
cation, we did not identify patient factors relevant to the
choice of implant. There was a strong influence of hos-
pital policy on implant choice. This was supported by
our ability to classify hospitals according to implant use.
Twenty-eight hospitals representing 85% of the fractures
used one implant for > 90% of the procedures during
the whole period or part of the period. In contrast to the
hospitals using one implant for all or almost all frac-
tures, 9 hospitals had a mixed pattern between SHS and
IMN throughout the period. In addition, 13 hospitals,
representing 42% of the fractures, changed to a mixed
implant pattern during the period. The mixed pattern
may be a more evidence-based practice.
Most randomized trials comparing IMN and SHS or
other implants for trochanteric fractures have been per-
formed without the use of TSP or with the TSP used at
the surgeon’s discretion in the SHS arm of the trial [3–5,
7]. The literature on TSP itself is scarce and mainly pre-
senting low-level evidence. Four biomechanical studies
examining the TSP in unstable trochanteric fracture
models compared an SHS with TSP to an IMN, report-
ing similar mechanical properties between the two im-
plants [8–11]. One paper compared SHS with and
without TSP and reported less displacement on loading
with the TSP [12]. Some clinical non-randomized
Table 4 Logistic regression analysis of the use of intramedullary nail (IMN) versus sliding hip screw (SHS) with or without
trochanteric support plate (TSP) on patient characteristics, fracture classification, and hospital characteristics. The analysis was
performed on 15,655 (10,600 SHS and 5055 IMN) cases with complete data
Logistic regression SHS versus IMN OR for IMN 95% CI for OR p
Patient characteristics
Higher age (years) 1.0 0.99–1.0 0.3
Female sex 1.0 0.89–1.1 0.6
ASA > 2 1.0 0.96–1.1 0.3
Cognitive impairment (yes) 1.1 0.98–1.2 0.1
Fracture type
AO/OTA 31A1 1
AO/OTA 31A2 1.8 1.6–1.9 < 0.001
AO/OTA 31A3 and subtrochanteric 5.3 4.5–6.2 < 0.001
Surgeon experience > 3 years 2.0 1.8–2.2 < 0.001
Hospital characteristics
Academic hospital 0.1 0.08–0.11 < 0.001
High-volume hospital (> 100 cases/year) 0.4 0.35–0.44 < 0.001
Urban hospital 0.2 0.16–0.20 < 0.001
Health region South-Eastern Norway 1
Health region Western Norway 2.6 2.3–3.0 < 0.001
Health region Central Norway 1.6 1.4–1.9 < 0.001
Health region Northern Norway 1.5 1.25–1.71 < 0.001
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comparisons exist, among them is a retrospective study
showing less lag screw sliding and fewer reoperations in
AO/OTA 31A2 fractures with the use of a TSP when
the lateral wall thickness was below 2.24 cm [13]. An-
other study reported less lag screw sliding with TSP
compared to SHS alone [14]. A register study of more
than 3000 unstable fractures, although only 158 operated
with TSP, found a tendency towards higher reoperation
rates with SHS alone compared to SHS with TSP and
IMN [15]. The only randomized trial examining the TSP
directly compared SHS with and without TSP in 100 un-
stable fractures. No clinically relevant differences be-
tween the groups were found, neither in complications,
secondary fracture displacement, nor functional results.
This study, including 100 patients in total, may have
been underpowered [16].
During our study period, we had no formal Norwegian
guidelines for implant choice for trochanteric fractures.
The Norwegian guidelines [17] (2018) recommends an
SHS for AO/OTA type A1 fractures and IMN for sub-
trochanteric fractures. For A2 fractures, the main recom-
mendation is an SHS with or without a TSP, with IMN
as an option. For A3 fractures, IMN is recommended,
but SHS with a TSP is stated as an option, depending on
surgeon preference. An extrapolation of the Norwegian
guidelines to the distribution of fractures reported in the
present study should most likely lead to a “mixed prac-
tice” pattern. We have identified two other national
guidelines discussing TSP for selected trochanteric frac-
tures. Both German-Austrian guidelines [18] and Danish
guidelines [19] discussed SHS with TSP as a possible al-
ternative to IMN in unstable fractures. A more recent
Danish algorithm did not include TSP as an option [20].
Other influential international guidelines, including from
the American Academy of Orthopaedic Surgeons [21]
and National Institute for Health and Care Excellence
[22], do not mention the TSP. A review from the USA
from 2004 recommended SHS for A1 and A2 fractures
and SHS with TSP, or IMN for A3 fractures [23]. A
more recent review from the same institution recom-
mended SHS for A1 and possibly A2.1 fractures and
IMN for other trochanteric and subtrochanteric frac-
tures. The TSP was discussed as an option for unstable
fractures in the latest review, but as an inferior implant
compared to IMN [2].
When the evidence is unclear or may support various
strategies, the choice of fracture treatment may depend
on surgeon preferences, as well as local or national tradi-
tions [1, 24, 25]. In Norway, interestingly, we identified
that implant choice is decided to a large degree on the
hospital level and to some degree by the hospital cir-
cumstances (e.g., rural versus urban and regional differ-
ences). An increased use of IMN has been described in
the USA, and both surgeon factors and hospital factors
have been used to explain the choice of IMN instead of
SHS [26]. A study based on Medicare data showed that
younger surgeons used more nails. Nails were also more
frequently used in high-volume teaching hospitals [24].
This contrasts with a survey among orthopedic surgeons
in the USA where a non-academic setting was associated
with IMN use, similar to our data [1]. The increased use
of IMN in trochanteric fractures has also been reported
in several studies from Europe [15, 27]. The increase of
IMN in Norway with a parallel decrease in TSP use is
thus in line with the development seen internationally.
Limitations of the present study include limited infor-
mation on surgeons’ qualifications, and there may be
surgeon-related variables influencing implant choice we
have missed. A potential weakness is the lack of valid-
ation of the fracture classification in the register, but
previous literature has indicated that the simple classifi-
cation used here is reliable and independent of surgeon
experience [28, 29]. A strength of this study is the large
number of fractures with relevant clinical and adminis-
trative data. The NHFR has been validated, and a high
completeness of reporting was found [6].
Conclusion
In Norway, the TSP was used for unstable fracture types.
In addition to fracture pattern, administrative and struc-
tural factors also explained the use of TSP, while patient
factors played a limited role. The variation in the pro-
portion of TSP between hospitals was considerable. We
found a decreasing trend of TSP use, whereas IMN use
increased. The ability of the TSP to avoid fixation failure
or provide better clinical outcomes remains unclear, and
larger studies addressing these issues are warranted.
Abbreviations
TSP: Trochanteric stabilizing plate; SHS: Sliding hip screw; IMN: Intramedullary
nail; NHFR: Norwegian Hip Fracture Register; OR: Odds ratio; SD: Standard
deviation; CI: Confidence interval
Acknowledgements
The authors wish to thank Bjarke Viberg for collecting the guidelines. In
addition, we want to thank the Norwegian orthopedic surgeons for
reporting trochanteric and subtrochanteric fractures to the Norwegian Hip
Fracture Register.
Authors’ contributions
CEA, JEG, and FF were responsible for planning the study. ED and CEA
performed the statistical analyses. CEA wrote the first draft. All authors
participated in the interpretation of the data and critical revision of the
manuscript. The authors read and approved the final manuscript.
Funding
None declared
Availability of data and materials
The data that support the findings of this study are available from The
Norwegian Hip Fracture Register, but restrictions apply to the availability of
these data, which were used under license for the current study, and so are
not publicly available. Data are however available from the authors upon
reasonable request and with permission from The Norwegian Hip Fracture
Register.
Alm et al. Journal of Orthopaedic Surgery and Research           (2021) 16:26 Page 7 of 8
Ethics approval and consent to participate
The NHFR has permission from the Norwegian Data Protection Authority to
collect and store data on patients with hip fractures (permission issued on
January 3, 2005; reference number 2004/1658-2 SVE/-). The patients signed
an informed consent, and in case they were not able to understand or sign,
their next of kin could sign the consent form on their behalf. The Norwegian







1Division of Orthopedic Surgery, Oslo University Hospital, Oslo, Norway.
2Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo,
Norway. 3The Norwegian Hip Fracture Register, Department of Orthopedic
Surgery, Haukeland University Hospital, Bergen, Norway. 4Department of
Clinical Medicine (K1), University of Bergen, Bergen, Norway.
Received: 19 October 2020 Accepted: 15 December 2020
References
1. Niu E, Yang A, Harris AH, Bishop J. Which fixation device is preferred for
surgical treatment of intertrochanteric hip fractures in the United States? A
survey of orthopaedic surgeons. Clin Orthop Relat Res. 2015;473(11):3647–
55.
2. Socci AR, Casemyr NE, Leslie MP, Baumgaertner MR. Implant options for the
treatment of intertrochanteric fractures of the hip. Rationale, evidence and
recommendations. Bone Joint J. 2017;99B(1):128–33.
3. Parker M, Raval P, Gjertsen JE. Nail or plate fixation for A3 trochanteric hip
fractures: a systematic review of randomised controlled trials. Injury. 2018;
49(7):1319–23.
4. Bhandari M, Schemitsch E, Jonsson A, Zlowodzki M, Haidukewych GJ.
Gamma nails revisited: gamma nails versus compression hip screws in the
management of intertrochanteric fractures of the hip: a meta-analysis. J
Orthop Trauma. 2009;23(6):460–4.
5. Parker MJ, Handoll HH. Gamma and other cephalocondylic intramedullary
nails versus extramedullary implants for extracapsular hip fractures in adults.
Cochrane Database Syst Rev. 2010;9:CD000093.
6. Furnes O, Gjertsen JE, Hallan G, Visnes H, Gundersen T, Fenstad A, et al.
Norwegian National Advisory Unit on Arthroplasty and hip fractures. Annual
report 2020http://nrlweb.ihelse.net/eng/Rapporter/Report2020_english.pdf.
Retrieved July 2020; 2020.
7. Matre K, Vinje T, Havelin LI, Gjertsen JE, Furnes O, Espehaug B, et al. TRIGEN
INTERTAN intramedullary nail versus sliding hip screw: a prospective,
randomized multicenter study on pain, function, and complications in 684
patients with an intertrochanteric or subtrochanteric fracture and one year
of follow-up. J Bone Joint Surg Am. 2013;95(3):200–8.
8. Bong MR, Patel V, Iesaka K, Egol KA, Kummer FJ, Koval KJ. Comparison of a
sliding hip screw with a trochanteric lateral support plate to an
intramedullary hip screw for fixation of unstable intertrochanteric hip
fractures: a cadaver study. J Trauma. 2004;56(4):791–4.
9. Bonnaire F, Weber A, Bösl O, Eckhardt C, Schwieger K, Linke B. “Cutting out”
in pertrochanteric fractures--problem of osteoporosis? Unfallchirurg. 2007;
110(5):425–32.
10. Knobe M, Nagel P, Maier KJ, Gradl G, Buecking B, Sonmez TT, et al.
Rotationally stable screw-anchor with locked trochanteric stabilizing plate
versus proximal femoral nail antirotation in the treatment of AO/OTA 31A2.
2 fracture: a biomechanical evaluation. J Orthop Trauma. 2016;30(1):e12–8.
11. Walmsley D, Nicayenzi B, Kuzyk PR, Machin A, Bougherara H, Schemitsch EH,
et al. Biomechanical analysis of the cephalomedullary nail versus the
trochanteric stabilizing plate for unstable intertrochanteric femur fractures.
Proc Inst Mech Eng H. 2016;230(12):1133–40.
12. Su ET, DeWal H, Kummer FJ, Koval KJ. The effect of an attachable lateral
support plate on the stability of intertrochanteric fracture fixation with a
sliding hip screw. J Trauma. 2003;55(3):504–8.
13. Hsu CE, Chiu YC, Tsai SH, Lin TC, Lee MH, Huang KC. Trochanter stabilising
plate improves treatment outcomes in AO/OTA 31-A2 intertrochanteric
fractures with critical thin femoral lateral walls. Injury. 2015;46(6):1047–53.
14. Madsen JE, Naess L, Aune AK, Alho A, Ekeland A, Stromsoe K. Dynamic hip
screw with trochanteric stabilizing plate in the treatment of unstable
proximal femoral fractures: a comparative study with the gamma nail and
compression hip screw. J Orthop Trauma. 1998;12(4):241–8.
15. Tucker A, Donnelly KJ, Rowan C, McDonald S, Foster AP. Is the best plate a
nail? A review of 3230 unstable intertrochanteric fractures of the proximal
femur. J Orthop Trauma. 2018;32(2):53–60.
16. Haddon J, Buciuto R, Johnsen LG. A prospective randomized trial of 100
patients using trochanteric support plates; worth their mettle? Injury. 2019;
50(3):733–7.
17. Ranhoff AH, Saltvedt I, Frihagen F, Raeder J, Maini S, Sletvold O.
Interdisciplinary care of hip fractures: orthogeriatric models, alternative
models, interdisciplinary teamwork. Best Pract Res Clin Rheumatol. 2019;
33(2):205–26.
18. Stürmer K, Bonnaire F, Dresing K, Frosch K, Kuderna H, Kübke R, et al.




19. Jensen C, Mainz H, Lamm M, Bang Foss N, Villadsen B, Ovesen O, et al.
Danish guidelines for patients with hip fracture; 2008. [Reference program
for patienter med hoftebrudd 2008.] Available from https://www.ortopaedi.
dk/fileadmin/Guidelines/Referenceprogrammer/Referenceprogram_for_
patienter_med_hoftebrud2008.pdf. Retrieved August 2020.
20. Palm H, Krasheninnikoff M, Holck K, Lemser T, Foss NB, Jacobsen S, et al. A
new algorithm for hip fracture surgery. Reoperation rate reduced from 18 %
to 12 % in 2,000 consecutive patients followed for 1 year. Acta Orthop.
2012;83(1):26–30.
21. Roberts KC, Brox WT. AAOS clinical practice guideline: management of hip
fractures in the elderly. J Am Acad Orthop Surg. 2015;23(2):138–40.
22. NICE. The management of hip fracture in adultsAvailable from https://www.
nice.org.uk/guidance/cg124. Retrieved May 2020. London: National Clinical
Guideline Centre; 2011.
23. Lindskog DM, Baumgaertner MR. Unstable intertrochanteric hip fractures in
the elderly. J Am Acad Orthop Surg. 2004;12(3):179–90.
24. Forte ML, Virnig BA, Eberly LE, Swiontkowski MF, Feldman R, Bhandari M,
et al. Provider factors associated with intramedullary nail use for
intertrochanteric hip fractures. J Bone Joint Surg Am. 2010;92(5):1105–14.
25. Hageman MG, Guitton TG, Ring D. How surgeons make decisions when the
evidence is inconclusive. J Hand Surg Am. 2013;38(6):1202–8.
26. Anglen JO, Weinstein JN, American Board of Orthopaedic Surgery Research
C. Nail or plate fixation of intertrochanteric hip fractures: changing pattern
of practice. A review of the American Board of Orthopaedic Surgery
Database. J Bone Joint Surg Am. 2008;90(4):700–7.
27. Ban I, Palm H, Birkelund L, Eschen J, Kring S, Brix M, et al. Implementing,
adapting, and validating an evidence-based algorithm for hip fracture
surgery. J Orthop Trauma. 2014;28(2):e21–e6.
28. Schipper IB, Steyerberg EW, Castelein RM, van Vugt AB. Reliability of the AO/
ASIF classification for pertrochanteric femoral fractures. Acta Orthop Scand.
2001;72(1):36–41.
29. Crijns TJ, Janssen SJ, Davis JT, Ring D, Sanchez HB. Reliability of the
classification of proximal femur fractures: does clinical experience matter?
Injury. 2018;49(4):819–23.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Alm et al. Journal of Orthopaedic Surgery and Research           (2021) 16:26 Page 8 of 8
